Invention Grant
- Patent Title: Use of IL-6/IL-6 chimera in Huntington's disease
- Patent Title (中): 在亨廷顿氏病中使用IL-6 / IL-6嵌合体
-
Application No.: US12717305Application Date: 2010-03-04
-
Publication No.: US08329654B2Publication Date: 2012-12-11
- Inventor: Nicole Deglon , Patrick Aebischer , Jean-Charles Bensadoun
- Applicant: Nicole Deglon , Patrick Aebischer , Jean-Charles Bensadoun
- Applicant Address: CH Aubonne
- Assignee: Ares Trading S.A.
- Current Assignee: Ares Trading S.A.
- Current Assignee Address: CH Aubonne
- Agency: Browdy and Neimark, PLLC
- Priority: EP00120045 20000914
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/16
Abstract:
The invention relates to the use of an IL-6R/IL-6 chimera, a mutein, isoform, fused protein, functional derivative, active fraction or circularly permutated derivative or a salt thereof, for the manufacture of a medicament for the treatment and/or prevention of Huntington's disease.
Public/Granted literature
- US20100166703A1 USE OF IL-6/IL-6 CHIMERA IN HUNTINGTON'S DISEASE Public/Granted day:2010-07-01
Information query
IPC分类:
